B & L Healthcare Products INC (labeler), 2025-04-23: DailyMed carries a 'FENBENDAZOLE 222 MG capsule' filed as a HUMAN OTC DRUG with dosage '2 capsules per day' and the disclaimer that the statements have not been evaluated by FDA – a listing, not an approval.
These statements have not been evaluated by the Food and DrugAdministration.
B & L Healthcare Products INC (labeler), 2025-04-23: DailyMed carries a 'FENBENDAZOLE 222 MG capsule' filed as a HUMAN OTC DRUG with dosage '2 capsules per day' and the disclaimer that the statements have not been evaluated by FDA – a listing, not an approval. C9 and C7 ('222 mg capsule'). Record fields: Product Type HUMAN OTC DRUG; NDC 85130-100-01/-02; route ORAL; purpose 'Dewormer'; dosage '2 capsules per day'; label carries the homeopathic-style disclaimer. This explains how a '222 mg capsule' can be sold in the US without any human approval: it sits in the OTC listing system with a structure/function disclaimer. openFDA's human-drug label query returns exactly two such fenbendazole listings (B & L Healthcare Products; Jiangxi Guchong Biotechnology, 'Dewormer for Dogs Only'), and Drugs@FDA returns none. Access date used as document_date. Also filed as FBB-38 (claims C7, C9). Study type: regulatory record.
